Genetic rescue of segmentation defect in MesP2-deficient mice by MesP1 gene replacement.
Gene knock-out and knock-in strategies are employed to investigate the function of MesP1. MesP1 belongs to the same family of bHLH transcription factors as MesP2. The early expression pattern observed in the early mesoderm at the onset of gastrulation is restricted to Mesp1, while the later expression pattern in the anterior presomitic mesoderm during somitogenesis is almost the same for Mesp1 as for Mesp2. Homozygous Mesp1 null mice exhibited growth retardation after 7.5 dpc and died before 10.5 dpc with many developmental defects. The function of MesP1 during somitogenesis was not clearly revealed because of their early death and the possible compensation by MesP2. In order to examine the functions of MesP1 during somitogenesis, we replaced the Mesp2 gene with Mesp1 cDNA, using a gene knock-in strategy. The introduced Mesp1 cDNA could rescue the defects caused by Mesp2 deficiency in a dosage-dependent manner. Mice which lacked Mesp2 expression but had four copies of the Mesp1 gene survived into the adulthood and were fertile. The skeletal defects and the reduction in expression of Notch1, Notch2 and FGFR-1 previously observed in Mesp2 null mice were almost completely rescued by the introduced MesP1. Thus, it is concluded that the functions of MesP1 during somitogenesis, like MesP2, are also mediated via notch-delta and FGF signaling systems.
Saga
Y
Y
Banyu Tsukuba Research Institute (Merck), Tsukuba, 300-26, Japan. saga@nihs.go.jp
D000015:Abnormalities, Multiple / Q000196:embryology / Q000235:genetics / Q000401:mortality; D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins; D001842:Bone and Bones / Q000002:abnormalities / Q000196:embryology; D002478:Cells, Cultured; D005314:Embryonic and Fetal Development / Q000235:genetics*; D005260:Female; D005326:Fetal Proteins / Q000235:genetics; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000502:physiology; D018507:Gene Expression Regulation, Developmental; D018390:Gene Targeting; D005796:Genes / Q000235:genetics*; D006257:Head / Q000002:abnormalities / Q000196:embryology; D006321:Heart / Q000196:embryology; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins / Q000235:genetics / Q000502:physiology; D008648:Mesoderm / Q000378:metabolism; D051379:Mice; D008813:Mice, Inbred ICR; D009154:Mutation; D009206:Myocardium / Q000473:pathology; D011247:Pregnancy; D051880:Receptors, Notch; D015398:Signal Transduction; D019170:Somites / Q000378:metabolism* / Q000473:pathology; D014157:Transcription Factors / Q000235:genetics* / Q000502:physiology; D014158:Transcription, Genetic
D051792:Basic Helix-Loop-Helix Proteins; D005326:Fetal Proteins; D005346:Fibroblast Growth Factors; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D051880:Receptors, Notch; D014157:Transcription Factors; C101538:Mesp1 protein, mouse; C107407:Mesp2 protein, mouse; C064045:delta protein